Jun 8 2023 Video RTP's Fourth Branch Podcast Utah v. Walsh: Latest Developments in the Challenges to the DOL's ESG Rule Jared Kelson, Brett Swearingen A Regulatory Transparency Project Webinar The plaintiffs in Utah v. Walsh filed a motion to halt implementation of the Department of Labor’s...
Jun 8 2023 Podcast RTP's Fourth Branch Podcast Utah v. Walsh: Latest Developments in the Challenges to the DOL's ESG Rule Jared Kelson, Brett Swearingen A Regulatory Transparency Project Webinar The plaintiffs in Utah v. Walsh filed a motion to halt implementation of the Department of Labor’s...
May 26 2023 Podcast RTP's Fourth Branch Podcast Tech Roundup Episode 18 – The Future of AI Regulation: Examining Risks and Rewards Neil Chilson, Adam Thierer Regulatory Transparency Project's Fourth Branch Podcast In this Tech Roundup episode, we delve into the discussions raised by the U.S. Senate...
May 24 2023 Video FedSoc Events Welcome & Plenary Session: Regulatory Review Reset? Anthony Philip Campau, Susan E. Dudley, Sally Katzen, Andrew Olmem EBRXI Earlier this month, the White House released much-anticipated changes to federal regulatory practices, including a...
May 24 2023 Podcast Welcome & Plenary Session: Regulatory Review Reset? Anthony Philip Campau, Susan E. Dudley, Sally Katzen, Andrew Olmem EBRXI Earlier this month, the White House released much-anticipated changes to federal regulatory practices, including a...
May 24 2023 Podcast RTP's Fourth Branch Podcast Explainer Episode 54 – Examining the Biden Administration's Proposed Changes to Cost-Benefit Analysis J. Howard Beales III, Karen Harned, Paul J. Ray Regulatory Transparency Project's Fourth Branch Podcast On April 6, 2023, the Biden Administration announced two new efforts to "modernize regulatory review"...
May 16 2023 Podcast RTP's Fourth Branch Podcast Explainer Episode 53 - Biologics, Biosimilars, and the Two-fold U.S. Approval Framework’s Possible Impact on Prices Roger D. Klein Regulatory Transparency Project's Fourth Branch Podcast Biosimilars, a category of biologic (medicine derived from a living organism), require approval, at least...
May 9 2023 Video FedSoc Forums The Evolution of HUD’s Affirmatively Furthering Fair Housing Rules: A Look at the Latest Proposed Regulation Braden H. Boucek, Paul Compton, Thomas Silverstein A Regulatory Transparency Project Webinar The United States Department of Housing and Urban Development’s Affirmatively Furthering Fair Housing rules have...
May 9 2023 Podcast FedSoc Forums The Evolution of HUD’s Affirmatively Furthering Fair Housing Rules: A Look at the Latest Proposed Regulation Braden H. Boucek, Paul Compton, Thomas Silverstein A Regulatory Transparency Project Webinar The United States Department of Housing and Urban Development’s Affirmatively Furthering Fair Housing rules have...
May 8 2023 Video RTP's Fourth Branch Podcast A Discussion on Central Bank Digital Currencies and the Future of Financial Privacy Paul Brigner, Tom Emmer, Jim Harper, Michael Mosier, William C. Hughes, J.W. Verret A Regulatory Transparency Project Webinar This webinar will explore central bank digital currencies (CBDCs) and the ongoing debates over financial...
Utah v. Walsh: Latest Developments in the Challenges to the DOL's ESG Rule
Jared Kelson, Brett Swearingen
A Regulatory Transparency Project Webinar
The plaintiffs in Utah v. Walsh filed a motion to halt implementation of the Department of Labor’s...
Utah v. Walsh: Latest Developments in the Challenges to the DOL's ESG Rule
Jared Kelson, Brett Swearingen
A Regulatory Transparency Project Webinar
The plaintiffs in Utah v. Walsh filed a motion to halt implementation of the Department of Labor’s...
Tech Roundup Episode 18 – The Future of AI Regulation: Examining Risks and Rewards
Neil Chilson, Adam Thierer
Regulatory Transparency Project's Fourth Branch Podcast
In this Tech Roundup episode, we delve into the discussions raised by the U.S. Senate...
Welcome & Plenary Session: Regulatory Review Reset?
Anthony Philip Campau, Susan E. Dudley, Sally Katzen, Andrew Olmem
EBRXI
Earlier this month, the White House released much-anticipated changes to federal regulatory practices, including a...
Welcome & Plenary Session: Regulatory Review Reset?
Anthony Philip Campau, Susan E. Dudley, Sally Katzen, Andrew Olmem
EBRXI
Earlier this month, the White House released much-anticipated changes to federal regulatory practices, including a...
Explainer Episode 54 – Examining the Biden Administration's Proposed Changes to Cost-Benefit Analysis
J. Howard Beales III, Karen Harned, Paul J. Ray
Regulatory Transparency Project's Fourth Branch Podcast
On April 6, 2023, the Biden Administration announced two new efforts to "modernize regulatory review"...
Explainer Episode 53 - Biologics, Biosimilars, and the Two-fold U.S. Approval Framework’s Possible Impact on Prices
Roger D. Klein
Regulatory Transparency Project's Fourth Branch Podcast
Biosimilars, a category of biologic (medicine derived from a living organism), require approval, at least...
The Evolution of HUD’s Affirmatively Furthering Fair Housing Rules: A Look at the Latest Proposed Regulation
Braden H. Boucek, Paul Compton, Thomas Silverstein
A Regulatory Transparency Project Webinar
The United States Department of Housing and Urban Development’s Affirmatively Furthering Fair Housing rules have...
The Evolution of HUD’s Affirmatively Furthering Fair Housing Rules: A Look at the Latest Proposed Regulation
Braden H. Boucek, Paul Compton, Thomas Silverstein
A Regulatory Transparency Project Webinar
The United States Department of Housing and Urban Development’s Affirmatively Furthering Fair Housing rules have...
A Discussion on Central Bank Digital Currencies and the Future of Financial Privacy
Paul Brigner, Tom Emmer, Jim Harper, Michael Mosier, William C. Hughes, J.W. Verret
A Regulatory Transparency Project Webinar
This webinar will explore central bank digital currencies (CBDCs) and the ongoing debates over financial...